Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

EuroPCR 2025 | BALI Trial: Intravascular Lithotripsy vs. Conventional Lesion Preparation in Calcified Lesions

Severely calcified coronary lesions represent a therapeutic challenge and have been associated with higher rates of failed percutaneous coronary intervention (PCI), and a negative impact on long-term outcomes. In this context, researchers evaluated whether intravascular lithotripsy (IVL) is superior to conventional lesion preparation prior stenting.

200 patients with angiographically severe calcification were included, and were randomized to either IVL or conventional preparation. All patients underwent optical coherence tomography (OCT), and rotational atherectomy was allowed if predefined criteria were met.

The primary endpoint included procedural failure (defined as non-viable stenting or ≥20% residual stenosis on OCT) and target vessel failure (TVF), which included acute MI, clinically driven revascularization, or cardiac death.

The conventional strategy involved non-compliant balloons (82%), cutting/scoring balloons (57%), and ultra-high-pressure balloons (3%). Rotational atherectomy was used in 31% of IVL patients and 42% of conventional patients.

Results showed a primary endpoint incidence of 35.4% in the IVL group vs. 51.5% in the conventional preparation group (RR 0.69; 95% CI 0.48–0.97; p=0.02).

Read also: EuroPCR 2025 | Multivessel PCI in Cardiogenic Shock: A Substudy from the DanGer Shock.

As regards periprocedural complications, no significant differences were observed in AMI rate, flow-limiting dissections, or perforations.

The authors concluded that in severely calcified lesions, IVL reduced the incidence of procedural failure or TVF at one year with no increase of procedure-related adverse events.

Presented by A. T. Kristensen during the Major Late Breaking Trials session, EuroPCR 2025, May 21, Paris, France.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...